The aspartate aminotransferase (AST) level, alanine aminotransferase (ALT) level, C-reactive protein (CRP) level, and model for end-stage liver disease (MELD) score were higher in patients with LC in the post-ACLF group compared with those in the non- and pre-ACLF groups. This evidence concerns the gene CRP and laryngotracheoesophageal cleft.